Relationship between mitochondrial DNA mutations and clinical characteristics in human lung cancer

Mitochondrion

Volumn 7, Issue 5, 2007, Pages 347-353

  Jin, Xiongjie ^a,b   Zhang, Jianjun ^a   Gao, Yanning ^a   Ding, Keyue ^b,c   Wang, Naishu ^d   Zhou, David ^d   Jen, Jin ^e   Cheng, Shujun ^a  

^a CANCER HOSPITAL   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d Alfa Scientific Designs Inc   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Lung cancer; Mitochondrial DNA; Mutation

Indexed keywords

MITOCHONDRIAL DNA;

ADENOSQUAMOUS CARCINOMA; ADULT; AGE; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENDER; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MITOCHONDRIAL GENETICS; POINT MUTATION; PRIORITY JOURNAL; SMOKING; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; DNA, MITOCHONDRIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, GENETIC;

EID: 34548127859     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2007.06.003     Document Type: Article

References (42)

1. Abu-Amero K.K., Alzahrani A.S., Zou M., and Shi Y. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines. Oncogene 24 (2005) 1455-1460
2. Aiyar A. The use of CLUSTAL W and CLUSTAL X for multiple sequence alignment. Methods Mol. Biol. 132 (2000) 221-241
3. Anderson S., Bankier A.T., Barrell B.G., deBrujin M.H.L., Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger F., Schreier P.H., Smith A.J., Staden R., and Young I.G. Sequence and organization of the human mitochondrial genome. Nature 290 (1981) 457-465
4. Brandon M., Baldi P., and Wallace D.C. Mitochondrial mutations in cancer. Oncogene 25 (2006) 4647-4662
5. Canter J.A., Kallianpur A.R., Parl F.F., and Millikan R.C. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 65 (2005) 8028-8033
6. Ewing B., Hillier L., Wendl M.C., and Green P. Base-calling of automated sequencer traces using Phred I. Accuracy assessment. Genome Res. 8 (1998) 175-185
7. Ewing B., and Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 8 (1998) 186-194
8. Fliss M.S., Usadel H., Caballero O.L., Wu L., Buta M.R., Eleff S.M., Jen J., and Sidransky D. Facile detection of mitochondrial DNA mutations in tumor and bodily fluids. Science 287 (2000) 2017-2019
9. Gordon D., Abajian C., and Green P. Consed: a graphical tool for sequence finishing. Genome Res. 8 (1998) 195-202
10. Habano W., Sugai T., Nakamura S.I., and Uesugi N. Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology 118 (2000) 835-841
11. Habano W., Nakamura S., and Sugai T. Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: Evidence for mismatch repair systems in mitochondrial genome. Oncogene 17 (1998) 1931-1937
12. Hecht S.S. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 3 (2002) 461-469
13. Higuchi M., Kudo T., Suzuki S., Evans T.T., Sasaki R., Wada Y., Shirakawa T., Sawyer J.R., and Gotoh A. Mitochondrial DNA determines androgen dependence in prostate cancer cell lines. Oncogene 25 (2006) 1437-1445
14. Isaacs C., Cavalli L.R., Cohen Y., Pennanen M., Sharkar L.K., Freedman M., Singh B., Liu M., Gallagher A., Rone J.D., Dickson R.B., Sidransky D., and Haddad B.R. Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patients. Breast Cancer Res. Treat. 84 (2004) 99-105
15. Jeronimo C., Nomoto S., Caballero O.L., Usadel H., Henrique R., Varzim G., Oliveria J., Lopes C., Fliss M.S., and Sidransky D. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20 (2001) 5195-5198
16. Jessie B.C., Sun C.Q., Irons H.R., Marshall F.F., Wallace D.C., and Petros J.A. Accumulation of mitochondrial DNA deletions in the malignant prostate of patients of different ages. Exp. Gerontol. 37 (2001) 169-174
17. Jin X.J., Zhang J.J., Song Y., Gao Y.N., and Cheng S.J. Mitochondrial DNA mutations in lung cancer. Ai Zheng 21 (2002) 715-718
18. Jones J.B., Song J.J., Hempen P.M., Parmigiani G., Hruban R.H., and Kern S.E. Detection of mitochondrial DNA mutation in pancreatic cancer offers a "Mass"-ive advantage over detection of nuclear DNA mutations. Cancer Res. 61 (2001) 1299-1304
19. Kagawa Y., Yanagisawa Y., Hasegawa K., Suzuki H., Yasuda K., Kudo H., Abe M., Matsuda S., Ishikawa Y., Tsuchiya N., Sato A., Umetsu K., and Kagawa Y. Single nucleotide polymorphisms of thrifty genes for energy metabolism: evolutionary origins and prospects for intervention to prevent obesity-related diseases. Biochem. Biophys. Res. Commun. 295 (2002) 207-222
20. Khaidakov M., and Shmookler Reis R.J. Possibility of selection against mtDNA mutations in tumors. Mol. Cancer. 4 (2005) 36
21. Khogali S.S., Mayosi B.M., Beattie J.M., McKenna W.J., Watkins H., and Poulton J. A common mitochondrial DNA variant associated with susceptibility to dilated cardiomyopathy in two different populations. Lancet 357 (2001) 1265-1267
22. King M.P., and Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246 (1989) 500-503
23. Larsson N.G., and Luft R. Revolution in mitochondrial medicine. FEBS Lett. 455 (1999) 199-202
24. Levin B.C., Cheng H.Y., and Reeder D.J. A Human mitochondrial DNA standard reference material for quality control in forensic identification, medical diagnosis, and mutation detection. Genomics 55 (1999) 135-146
25. Matsuyama W., Nakagawa M., Wakimoto J., Hirotsu Y., Kawabata M., and Osame M. Mitochondrial DNA mutation correlates with stage progression and prognosis in non-small cell lung cancer. Hum. Mutat. 21 (2003) 441-443
26. Nishikawa M., Nishiguchi S., Shiomi S., Tamori A., Koh N., Takeda T., Kubo S., Hirohashi K., Kinoshita H., Sato E., and Inoue M. Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res. 61 (2001) 1843-1845
27. Parfait B., Rustin P., Munnich A., and Rotig A. Co-amplification of nuclear pseudogenes and assessment of heteroplasmy of mitochondrial DNA mutations. Biochem. Biophys. Res. Commun 247 (1998) 57-59
28. Penta J.S., Johnson F.M., Wachsman J.T., and Copeland W.C. Mitochondrial DNA in human malignancy. Mutation Res. 488 (2001) 119-133
29. Petros J.A., Baumann A.K., Ruiz-Pesini E., Amin M.B., Sun C.Q., Hall J., Lim S., Issa M.M., Flanders W.D., Hosseini S.H., Marshall F.F., and Wallace D.C. MtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl. Acad. Sci. USA 102 (2005) 719-724
30. Polyak K., Li Y., Zhu H., Lengauer C., Willson J.K., Markowitz S.D., Trush M.A., Kinzler K.W., and Vogelstein B. Somatic mutations of the mitochondrial DNA genome in human colorectal tumors. Nat. Genet. 20 (1998) 291-293
31. Richard S.M., Bailliet G., Paez G.L., Bianchi M.S., Peltomaki P., and Bianchi N.O. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. 60 (2000) 4231-4237
32. Rosson D., and Keshgegian A.A. Frequent mutations in the mitochondrial control region DNA in breast tissue. Cancer Lett. 215 (2004) 89-94
33. Shidara Y., Yamagata K., Kanamori T., Nakano Kazutoshi., Kwong J.Q., Manfredi G., Oda H., and Ohta S. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res. 65 (2005) 1655-1663
34. Shields P.G. Molecular epidemiology of smoking and lung cancer. Oncogene 21 (2002) 6870-6876
35. Simon D.K., and Johns D.R. Mitochondrial disorders: clinical and genetic features. Ann. Rev. Med. 50 (1999) 111-127
36. Tamori A., Nishiguchi S., Nishikawa M., Kubo S., Koh N., Hirohashi K., Shiomi S., and Inoue M. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma. J. Gastroenterol. 39 (2004) 1063-1068
37. Wallace D.C. Mitochondrial diseases in man and mouse. Science 283 (1999) 1482-1488
38. Wallace D.C. Mitochondrial DNA sequence variation in human evolution and disease. Proc. Natl. Acad. Sci. USA 91 (1994) 8739-8746
39. Wardell T.M., Ferguson E., Chinnery P.F., Borthwick G.M., Taylor R.W., Jackson G., Craft A., Lightowlers R.N., Howell N., and Turnbull D.M. Changes in the human mitochondrial genome after treatment of malignant disease. Mutat. Res. 525 (2003) 19-27
40. Yeh J.J., Lunetta K.L., van Orsouw N.J., Moore Jr. F.D., Mutter G.L., Vijg J., Dahia P.L., and Eng C. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene 19 (2000) 2060-2066
41. Zhang J., Fan Z., Gao Y., Xiao Z., Li C., An Q., and Cheng S. Detecting bladder cancer in the Chinese by microsatellite analysis: ethnic and etiologic considerations. J. Natl. Cancer. Inst. 93 (2001) 45-50
42. Zhu W., Qin W., Bradley P., Wessel A., Puckett C.L., and Sauter E.R. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis 26 (2005) 142-152